跳至主要内容
临床试验/JPRN-UMIN000022951
JPRN-UMIN000022951已完成未知

Hypofractionated intensity-modulated radiation therapy for prostate cancer - Hypofractionated intensity-modulated radiation therapy for prostate cancer

Department of Radiation Oncology, Graduate School of Medical and Dental Sciences, Niigata University0 个研究点目标入组 39 人开始时间: 2016年6月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patients who received radiotherapy for prostate. 2) Patients who received surgery for prostate. 3) Patients with uncontrolled active infection. 4) Cancer patients with a duplication of activity. 5) Patients with serious complications (uncontrollable collagen disease, heart disease, pulmonary disease, liver disease). 6) Mental diseases which prevent from registration of this trial. 7) Patients who received chemotherapy for prostate cancer. 8) Patients with inflammatory bowel disease. 9) Patients with severe or uncontrollable diabetes mellitus. 10) Risk organs are too close to the PTV to keep dose constraints. 11) Patients judged inappropriate for this study by the physicians.

研究者

发起方
Department of Radiation Oncology, Graduate School of Medical and Dental Sciences, Niigata University

相似试验